Wesley Blackaby

2.1k total citations
14 papers, 377 citations indexed

About

Wesley Blackaby is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Wesley Blackaby has authored 14 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Wesley Blackaby's work include Neuroscience and Neuropharmacology Research (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers) and RNA modifications and cancer (3 papers). Wesley Blackaby is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers) and RNA modifications and cancer (3 papers). Wesley Blackaby collaborates with scholars based in United Kingdom, United States and Portugal. Wesley Blackaby's co-authors include Richard T. Lewis, John Atack, Keith A. Wafford, Andrew Pike, George Marshall, Simon Goodacre, José L. Castro, David J. Hallett, Leslie J. Street and Joanna L. Stanley and has published in prestigious journals such as Genes & Development, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Wesley Blackaby

14 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wesley Blackaby United Kingdom	10	196	178	55	49	18	14	377
Mark J. Morris United States	8	508 2.6×	50 0.3×	47 0.9×	12 0.2×	18 1.0×	11	669
Rosy Sher France	7	81 0.4×	204 1.1×	34 0.6×	59 1.2×	23 1.3×	9	303
Felix Major Germany	12	297 1.5×	171 1.0×	38 0.7×	41 0.8×	38 2.1×	15	389
François Crestey Denmark	13	184 0.9×	290 1.6×	21 0.4×	26 0.5×	15 0.8×	27	404
Seong Jun Park South Korea	14	202 1.0×	344 1.9×	49 0.9×	8 0.2×	15 0.8×	30	543
Linus S. Lin United States	13	157 0.8×	189 1.1×	82 1.5×	10 0.2×	18 1.0×	20	401
Srinivas K. Battina United States	10	137 0.7×	130 0.7×	18 0.3×	14 0.3×	10 0.6×	12	327
David A. Carcache Switzerland	13	193 1.0×	187 1.1×	47 0.9×	9 0.2×	30 1.7×	19	408
Esther Torrente Spain	10	92 0.5×	230 1.3×	20 0.4×	51 1.0×	13 0.7×	20	432
Balu Balasubramanian United States	13	155 0.8×	261 1.5×	13 0.2×	25 0.5×	40 2.2×	33	439

Countries citing papers authored by Wesley Blackaby

Since Specialization

Citations

This map shows the geographic impact of Wesley Blackaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wesley Blackaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wesley Blackaby more than expected).

Fields of papers citing papers by Wesley Blackaby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wesley Blackaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wesley Blackaby. The network helps show where Wesley Blackaby may publish in the future.

Co-authorship network of co-authors of Wesley Blackaby

This figure shows the co-authorship network connecting the top 25 collaborators of Wesley Blackaby. A scholar is included among the top collaborators of Wesley Blackaby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wesley Blackaby. Wesley Blackaby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Burgess, Hannah M., Daniel P. Depledge, Kalanghad Puthankalam Srinivas, et al.. (2021). Targeting the m⁶A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication. Genes & Development. 35(13-14). 1005–1019. 90 indexed citations

Linney, Ian D., Andrea Rizzi, Maurizio Delcanale, et al.. (2021). Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β2 agonist (MABA) for the treatment of chronic obstructive pulmonary disease (COPD). Bioorganic & Medicinal Chemistry Letters. 41. 127975–127975. 3 indexed citations

Albertella, Mark R., Wesley Blackaby, Richard Fosbeary, et al.. (2019). Abstract B126: A small molecule inhibitor of the RNA m6A writer METTL3 inhibits the development of acute myeloid leukemia (AML) in vivo. Molecular Cancer Therapeutics. 18(12_Supplement). B126–B126. 3 indexed citations

Tzelepis, Konstantinos, Étienne De Braekeleer, Eliza Yankova, et al.. (2019). Pharmacological Inhibition of the RNA m6a Writer METTL3 As a Novel Therapeutic Strategy for Acute Myeloid Leukemia. Blood. 134(Supplement_1). 403–403. 22 indexed citations

Wang, Xiaojing, Wesley Blackaby, D. Nash, et al.. (2015). Probing Mechanisms of CYP3A Time-Dependent Inhibition Using a Truncated Model System. ACS Medicinal Chemistry Letters. 6(8). 925–929. 9 indexed citations

Blackaby, Wesley, Richard T. Lewis, Simon Goodacre, et al.. (2010). Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1. ACS Medicinal Chemistry Letters. 1(7). 350–354. 14 indexed citations

Blackaby, Wesley, Simon Goodacre, Andrew Pike, et al.. (2009). Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(8). 2235–2239. 7 indexed citations

Blackaby, Wesley, et al.. (2006). Synthesis of pyrido[2,3-d]pyridazines and pyrazino[2,3-d]-pyridazines—novel classes of GABAA receptor benzodiazepine binding site ligands. Tetrahedron Letters. 47(13). 2257–2260. 9 indexed citations

Lewis, Richard T., Wesley Blackaby, Timothy J. Blackburn, et al.. (2006). A Pyridazine Series of α2/α3 Subtype Selective GABA_A Agonists for the Treatment of Anxiety. Journal of Medicinal Chemistry. 49(8). 2600–2610. 25 indexed citations

10.

Blackaby, Wesley, John Atack, Frances A. Bromidge, et al.. (2006). Imidazo[1,2-a]pyrimidines as functionally selective GABAA ligands. Bioorganic & Medicinal Chemistry Letters. 16(5). 1175–1179. 36 indexed citations

11.

Atack, John, Andy Pike, George Marshall, et al.. (2006). The in vivo properties of pagoclone in rat are most likely mediated by 5′-hydroxy pagoclone. Neuropharmacology. 50(6). 677–689. 14 indexed citations

12.

Blackaby, Wesley, John Atack, Frances A. Bromidge, et al.. (2005). Pyrazolopyridinones as functionally selective GABAA ligands. Bioorganic & Medicinal Chemistry Letters. 15(22). 4998–5002. 15 indexed citations

13.

Goodacre, Simon, Leslie J. Street, David J. Hallett, et al.. (2005). Imidazo[1,2-a]pyrimidines as Functionally Selective and Orally Bioavailable GABA_Aα2/α3 Binding Site Agonists for the Treatment of Anxiety Disorders. Journal of Medicinal Chemistry. 49(1). 35–38. 121 indexed citations

14.

Attard, George S., Wesley Blackaby, & Andrew R. Leach. (1994). The aggregation behaviour of two structurally isomeric glycolipids. Chemistry and Physics of Lipids. 74(1). 83–91. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact